Search
-
News
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.
… Tuesday, July 28, 2020 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since U.S. News & World Report established the prestigious rankings more than 30 years ago
-
News
During the AACR COVID-19 and Cancer Meeting, several MSK physicians presented information about providing safe patient care, vaccines, and clinical research.
… Friday, February 12, 2021 At the American Association for Cancer Research (AACR) COVID-19 and Cancer Meeting on February 3-5, 2021, oncology experts from around the world tuned in virtually to discuss the impact of COVID-19 on cancer care. The meeting featured presentations of emerging data in basic,
-
News
Practical tips for caregivers helping an older relative or friend make decisions about cancer treatment.
… Friday, November 25, 2016 Summary An older adult who is diagnosed with cancer may need help making treatment decisions. Our Geriatrics Service Chief discusses how to lend support. Highlights Decisions should be made based on each individual’s unique situation. It’s important to consider the goals of
-
News
A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
… Friday, June 9, 2017 Two years ago at the annual meeting of the American Society of Clinical Oncology, researchers from Johns Hopkins wowed an audience with results from a recent immunotherapy clinical trial. People with a type of colorectal cancer that bore a genetic abnormality called mismatch repair
-
News
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
… Wednesday, May 18, 2022 DNA sequencing tests that look for mutations in cancer-associated genes have become the standard of care at leading centers, including at Memorial Sloan Kettering Cancer Center (MSK). MSK’s test, called MSK-IMPACT™, can detect mutations in 500-plus cancer-related genes. This information
-
News
For the first time, scientists have shown that the gene APC, which is mutated in the vast majority of colorectal cancers, might be a promising target for future therapies.
… Wednesday, July 1, 2015 Summary Working in mice, Memorial Sloan Kettering scientists have found that genetic alterations in the APC gene, which are found in more than 90 percent of colorectal cancers, play an important role in driving the disease. The researchers are now asking whether potential drugs
-
News
Physicians and researchers at MSK Kids, Memorial Sloan Kettering Cancer Center’s dedicated pediatric cancer program, completed several groundbreaking research studies in 2023. These studies, which focused on pediatric disease mechanisms, paved the way to promising new therapeutic approaches for improving patient outcomes.
… Tuesday, December 26, 2023 Physicians and researchers at MSK Kids , Memorial Sloan Kettering Cancer Center’s dedicated pediatric cancer program, completed several groundbreaking research studies in 2023. These studies, which focused on pediatric disease mechanisms, paved the way to promising new therapeutic
-
MSK News
In 1971, Richard Nixon launched a “war on cancer.” It’s still raging.
… Wednesday, January 1, 2020 In 2016, when Vice President Joseph Biden announced the “Cancer Moonshot” initiative , many in the scientific world felt a twinge of déjà vu. This wasn’t the first time that officials in the US government had set their sights on an ambitious plan to conquer cancer. In fact,
-
News
On Feburary 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research at Memorial Sloan Kettering Cancer Center.
… Saturday, February 20, 2010 On February 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research at Memorial Sloan Kettering Cancer Center. The event, Cycle for Survival , was founded
-
News
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
… Tuesday, October 21, 2014 Summary MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells. Bacterial infections can cause major problems for people undergoing treatment for cancer and other diseases. The concern is especially